119 related articles for article (PubMed ID: 37247782)
1. Geranylgeranoic acid, a bioactive and endogenous fatty acid in mammals: a review.
Shidoji Y
J Lipid Res; 2023 Jul; 64(7):100396. PubMed ID: 37247782
[TBL] [Abstract][Full Text] [Related]
2. TLR4-mediated pyroptosis in human hepatoma-derived HuH-7 cells induced by a branched-chain polyunsaturated fatty acid, geranylgeranoic acid.
Yabuta S; Shidoji Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32270855
[TBL] [Abstract][Full Text] [Related]
3. Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.
Shidoji Y; Tabata Y
J Lipid Res; 2019 Mar; 60(3):579-593. PubMed ID: 30622150
[TBL] [Abstract][Full Text] [Related]
4. Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells.
Tabata Y; Shidoji Y
J Lipid Res; 2020 May; 61(5):778-789. PubMed ID: 32094232
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated Branched-Chain Fatty Acid Geranylgeranoic Acid Induces Unfolded Protein Response in Human Hepatoma Cells.
Iwao C; Shidoji Y
PLoS One; 2015; 10(7):e0132761. PubMed ID: 26186544
[TBL] [Abstract][Full Text] [Related]
6. Age-Dependent Decrease in Hepatic Geranylgeranoic Acid Content in C3H/HeN Mice and Its Oral Supplementation Prevents Spontaneous Hepatoma.
Tabata Y; Omori M; Shidoji Y
Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564450
[TBL] [Abstract][Full Text] [Related]
7. A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis.
Shidoji Y; Iwao C
Biochem Biophys Rep; 2021 Dec; 28():101176. PubMed ID: 34869922
[TBL] [Abstract][Full Text] [Related]
8. Geranylgeraniol oxidase activity involved in oxidative formation of geranylgeranoic acid in human hepatoma cells.
Mitake M; Shidoji Y
Biomed Res; 2012 Feb; 33(1):15-24. PubMed ID: 22361882
[TBL] [Abstract][Full Text] [Related]
9. Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbs.
Shidoji Y; Ogawa H
J Lipid Res; 2004 Jun; 45(6):1092-103. PubMed ID: 15060084
[TBL] [Abstract][Full Text] [Related]
10. Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in
Tabata Y; Shidoji Y
Metabolites; 2022 Feb; 12(2):. PubMed ID: 35208214
[TBL] [Abstract][Full Text] [Related]
11. Induction of an incomplete autophagic response by cancer-preventive geranylgeranoic acid (GGA) in a human hepatoma-derived cell line.
Okamoto K; Sakimoto Y; Imai K; Senoo H; Shidoji Y
Biochem J; 2011 Nov; 440(1):63-71. PubMed ID: 21787360
[TBL] [Abstract][Full Text] [Related]
12. Induction of nuclear translocation of mutant cytoplasmic p53 by geranylgeranoic acid in a human hepatoma cell line.
Iwao C; Shidoji Y
Sci Rep; 2014 Mar; 4():4419. PubMed ID: 24658405
[TBL] [Abstract][Full Text] [Related]
13. Retinoid agonist activities of synthetic geranyl geranoic acid derivatives.
Araki H; Shidoji Y; Yamada Y; Moriwaki H; Muto Y
Biochem Biophys Res Commun; 1995 Apr; 209(1):66-72. PubMed ID: 7726866
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatment.
Iwao C; Shidoji Y
Biomed Res; 2015; 36(6):371-81. PubMed ID: 26700591
[TBL] [Abstract][Full Text] [Related]
15. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
16. Increase in plasma concentrations of geranylgeranoic Acid after turmeric tablet intake by healthy volunteers.
Mitake M; Ogawa H; Uebaba K; Shidoji Y
J Clin Biochem Nutr; 2010 May; 46(3):252-8. PubMed ID: 20490321
[TBL] [Abstract][Full Text] [Related]
17. Rapid downregulation of cyclin D1 induced by geranylgeranoic acid in human hepatoma cells.
Shimonishi S; Muraguchi T; Mitake M; Sakane C; Okamoto K; Shidoji Y
Nutr Cancer; 2012 Apr; 64(3):473-80. PubMed ID: 22369110
[TBL] [Abstract][Full Text] [Related]
18. Rapid loss in the mitochondrial membrane potential during geranylgeranoic acid-induced apoptosis.
Shidoji Y; Nakamura N; Moriwaki H; Muto Y
Biochem Biophys Res Commun; 1997 Jan; 230(1):58-63. PubMed ID: 9020060
[TBL] [Abstract][Full Text] [Related]
19. Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells.
Sakane C; Shidoji Y
J Neurooncol; 2011 Sep; 104(3):705-13. PubMed ID: 21373967
[TBL] [Abstract][Full Text] [Related]
20. Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice.
Senoo T; Sasaki R; Akazawa Y; Ichikawa T; Miuma S; Miyaaki H; Taura N; Nakao K
BMC Gastroenterol; 2018 Feb; 18(1):34. PubMed ID: 29486718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
